ask="14.22"
ask_size="200"
average_daily_volume="1895100"
bid="13.00"
bid_size="100"
book_value="-0.25"
change="+0.12"
change_from_200_day_moving_average="2.36"
change_from_50_day_moving_average="1.35"
change_from_52_week_high="-0.61"
change_From_52_week_low="6.25"
change_in_percent="+0.88%"
close="13.77"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.81"
ebitda="-80.80M"
eps_estimate_current_year="-0.97"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.80"
ex_dividend_date="N/A"
float_shares="94778000"
high="13.81"
high_52_weeks="14.38"
last_trade_date="3/10/2017"
last_trade_price="13.77"
last_trade_size="67800"
last_trade_time="4:00pm"
low="13.39"
low_52_weeks="7.52"
market_capitalization="1.77B"
moving_average_200_day="11.41"
moving_average_50_day="12.42"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="13.72"
pe_ratio="N/A"
peg_ratio="-1.98"
percent_change_from_200_day_moving_average="+20.65%"
percent_change_from_50_day_moving_average="+10.88%"
percent_change_from_52_week_high="-4.24%"
percent_change_from_52_week_low="+83.11%"
previous_close="13.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="11.93"
revenue="146.69M"
shares_outstanding="128198000"
short_ratio="17.97"
stock_exchange="NMS"
symbol="HALO"
volume="846842"
weeks_range_52="7.52 - 14.38"
